Niki BioSolutions, Inc. (NIKI) Net Cash Flow (2017 - 2025)
Niki BioSolutions' (NIKI) quarterly Net Cash Flow came in at $56577.0 in Q4 2025, up 285.19% YoY from $14688.0 in Q4 2024, and up 298.36% on a QoQ basis from -$28523.0 in Q3 2025.
Niki BioSolutions, Inc. (NIKI) Net Cash Flow (2017 - 2025) Analysis & Trends
Niki BioSolutions (NIKI) has 3 years of Net Cash Flow data on file, last reported at $56577.0 in Q4 2025.
- Quarterly Net Cash Flow rose 285.19% year-over-year to $56577.0 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $42742.0 (down 21.05% YoY) and the FY2025 annual result came in at $2.6 million, up 327.97% from the prior year.
- Net Cash Flow advanced to $56577.0 in Q4 2025, from -$28523.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $56577.0 in Q4 2025 to a low of -$28523.0 in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | 56,577.00 |
| Nov 30, 2025 | 56,577.00 |
| Aug 31, 2025 | -28,523.00 |
| Aug 31, 2025 | -28,523.00 |
| Nov 30, 2024 | 14,688.00 |
| Nov 30, 2024 | 14,688.00 |
| Aug 31, 2024 | 39,451.00 |
| Aug 31, 2024 | 39,451.00 |
| Dec 31, 2017 | 16.10 Mn |
| Dec 31, 2017 | 16.10 Mn |